These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 21369648)

  • 1. Regression of internal melanoma metastases following application of topical imiquimod to overlying skin.
    Miller AK; Dusing R; Meggison A; Aires D
    J Drugs Dermatol; 2011 Mar; 10(3):302-5. PubMed ID: 21369648
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Imiquimod, a topical immune response modifier, in the treatment of cutaneous metastases of malignant melanoma.
    Bong AB; Bonnekoh B; Franke I; Schön M; Ulrich J; Gollnick H
    Dermatology; 2002; 205(2):135-8. PubMed ID: 12218228
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Topical treatment of melanoma skin metastases with imiquimod].
    Sigüenza M; Pizarro A; Mayor M; Vidaurrázaga C; Miralles L; González-Beato M; Casado M
    Actas Dermosifiliogr; 2005 Mar; 96(2):111-5. PubMed ID: 16476347
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Successful treatment of malignant melanoma in situ with topical 5% imiquimod cream.
    Ray CM; Kluk M; Grin CM; Grant-Kels JM
    Int J Dermatol; 2005 May; 44(5):428-34. PubMed ID: 15869545
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Topical treatment of cutaneous metastases of malignant melanoma using combined imiquimod and 5-fluorouracil].
    Florin V; Vercambre-Darras S; Piette F; Mortier L
    Ann Dermatol Venereol; 2008; 135(8-9):603-4. PubMed ID: 18789300
    [No Abstract]   [Full Text] [Related]  

  • 6. Successful treatment of persistent melanoma in situ with 5% imiquimod cream.
    Muñoz CM; Sánchez JL; Martín-García RF
    Dermatol Surg; 2004 Dec; 30(12 Pt 2):1543-5. PubMed ID: 15606836
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 100% Complete response rate in patients with cutaneous metastatic melanoma treated with intralesional interleukin (IL)-2, imiquimod, and topical retinoid combination therapy: results of a case series.
    Shi VY; Tran K; Patel F; Leventhal J; Konia T; Fung MA; Wilken R; Garcia MS; Fitzmaurice SD; Joo J; Monjazeb AM; Burrall BA; King B; Martinez S; Christensen SD; Maverakis E
    J Am Acad Dermatol; 2015 Oct; 73(4):645-54. PubMed ID: 26259990
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo and in situ modulation of the expression of genes involved in metastasis and angiogenesis in a patient treated with topical imiquimod for melanoma skin metastases.
    Hesling C; D'Incan M; Mansard S; Franck F; Corbin-Duval A; Chèvenet C; Déchelotte P; Madelmont JC; Veyre A; Souteyrand P; Bignon YJ
    Br J Dermatol; 2004 Apr; 150(4):761-7. PubMed ID: 15099376
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clearance of invasive melanoma with topical imiquimod.
    Moon SD; Spencer JM
    J Drugs Dermatol; 2013 Jan; 12(1):107-8. PubMed ID: 23377337
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [In-transit metastasis in melanoma: Efficacy of topical imiquimod combined with carbon dioxide laser or with electrocautery].
    Elfatoiki FZ; Longvert C; Clerici T; Bourgault-Villada I; Roudier-Pujol C; Vasseur E; Saiag P
    Ann Dermatol Venereol; 2014 Feb; 141(2):106-10. PubMed ID: 24507204
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Melanoma in situ treated successfully using imiquimod after nonclearance with surgery: review of the literature.
    Ellis LZ; Cohen JL; High W; Stewart L
    Dermatol Surg; 2012 Jun; 38(6):937-46. PubMed ID: 22338583
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adjuvant treatment with topical 5% imiquimod cream for resected stage IIIb melanoma.
    Tiodorovic-Zivkovic D; Argenziano G; Catricalà C; Ferrara G; Giorgio CM; Moscarella E; Zalaudek I
    Eur J Dermatol; 2011; 21(3):410-1. PubMed ID: 21515443
    [No Abstract]   [Full Text] [Related]  

  • 13. Complete remission of cutaneous and subcutaneous melanoma metastases of the scalp with imiquimod therapy.
    Heber G; Helbig D; Pönitzsch I; Wetzig T; Harth W; Simon JC
    J Dtsch Dermatol Ges; 2009 Jun; 7(6):534-6. PubMed ID: 19250248
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Topical treatment of cutaneous metastases of malignant melanoma using combined imiquimod and 5-fluorouracil.
    Florin V; Desmedt E; Vercambre-Darras S; Mortier L
    Invest New Drugs; 2012 Aug; 30(4):1641-5. PubMed ID: 21748297
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Photodynamic therapy versus topical imiquimod versus topical fluorouracil for treatment of superficial basal-cell carcinoma: a single blind, non-inferiority, randomised controlled trial.
    Arits AH; Mosterd K; Essers BA; Spoorenberg E; Sommer A; De Rooij MJ; van Pelt HP; Quaedvlieg PJ; Krekels GA; van Neer PA; Rijzewijk JJ; van Geest AJ; Steijlen PM; Nelemans PJ; Kelleners-Smeets NW
    Lancet Oncol; 2013 Jun; 14(7):647-54. PubMed ID: 23683751
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of in-transit and metastatic melanoma in two patients treated with ipilimumab and topical imiquimod.
    Joseph RW; Cappel M; Tzou K; Bagaria S; Gilstrap C; Swaika A; Jambusaria-Pahlajani A
    Melanoma Res; 2016 Aug; 26(4):409-12. PubMed ID: 27138458
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Imiquimod, pegylated interferon-alpha-2b and interleukin-2 in the treatment of cutaneous melanoma metastases].
    Loquai C; Nashan D; Metze D; Beiteke U; Rüping KW; Luger TA; Grabbe S
    Hautarzt; 2004 Feb; 55(2):176-81. PubMed ID: 14968329
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complete regression of subcutaneous and cutaneous metastatic melanoma with high-dose intralesional interleukin 2 in combination with topical imiquimod and retinoid cream.
    Garcia MS; Ono Y; Martinez SR; Chen SL; Goodarzi H; Phan T; Wehrli LN; Miyamura Y; Fung MA; Maverakis E
    Melanoma Res; 2011 Jun; 21(3):235-43. PubMed ID: 21464773
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acral lentiginous melanoma treated with topical imiquimod cream: possible cooperation between drug and tumour cells.
    Savarese I; Papi F; D'Errico A; Gori A; Grazzini M; Vannucchi M; Massi D; De Giorgi V
    Clin Exp Dermatol; 2015 Jan; 40(1):27-30. PubMed ID: 25252087
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Death receptor-independent apoptosis in malignant melanoma induced by the small-molecule immune response modifier imiquimod.
    Schön MP; Wienrich BG; Drewniok C; Bong AB; Eberle J; Geilen CC; Gollnick H; Schön M
    J Invest Dermatol; 2004 May; 122(5):1266-76. PubMed ID: 15140231
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.